Search Results - "Scotet, Emmanuel"

Refine Results
  1. 1

    Emerging Challenges of Preclinical Models of Anti-tumor Immunotherapeutic Strategies Utilizing Vγ9Vδ2 T Cells by Joalland, Noémie, Scotet, Emmanuel

    Published in Frontiers in immunology (22-05-2020)
    “…Despite recent advances, the eradication of cancers still represents a challenge which justifies the exploration of additional therapeutic strategies such as…”
    Get full text
    Journal Article
  2. 2
  3. 3
  4. 4

    The Juxtamembrane Domain of Butyrophilin BTN3A1 Controls Phosphoantigen-Mediated Activation of Human Vγ9Vδ2 T Cells by Peigné, Cassie-Marie, Léger, Alexandra, Gesnel, Marie-Claude, Konczak, Fabienne, Olive, Daniel, Bonneville, Marc, Breathnach, Richard, Scotet, Emmanuel

    Published in The Journal of immunology (1950) (01-06-2017)
    “…Vγ9Vδ2 T lymphocytes are the major human peripheral γδ T cell subset, with broad reactivity against stressed human cells, including tumor cells. Vγ9Vδ2 T cells…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Towards Deciphering the Hidden Mechanisms That Contribute to the Antigenic Activation Process of Human Vγ9Vδ2 T Cells by Boutin, Lola, Scotet, Emmanuel

    Published in Frontiers in immunology (20-04-2018)
    “…Vγ9Vδ2 T cells represent a major unconventional γδ T cell subset located in the peripheral blood of adults in humans and several non-human primates…”
    Get full text
    Journal Article
  7. 7
  8. 8

    The antitumor activity of human Vγ9Vδ2 T cells is impaired by TGF-β through significant phenotype, transcriptomic and metabolic changes by Rafia, Chirine, Loizeau, Clément, Renoult, Ophélie, Harly, Christelle, Pecqueur, Claire, Joalland, Noémie, Scotet, Emmanuel

    Published in Frontiers in immunology (19-01-2023)
    “…Despite significant advances, the eradication of cancer remains a clinical challenge which justifies the urgent exploration of additional therapeutic…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Combined chemotherapy and allogeneic human Vγ9Vδ2 T lymphocyte-immunotherapies efficiently control the development of human epithelial ovarian cancer cells in vivo by Joalland, Noémie, Lafrance, Laura, Oullier, Thibauld, Marionneau-Lambot, Séverine, Loussouarn, Delphine, Jarry, Ulrich, Scotet, Emmanuel

    Published in Oncoimmunology (02-11-2019)
    “…Epithelial ovarian cancer (EOC) represents 5% of human gynecologic cancers in the world, is heterogeneous and highly invasive with a dismal prognosis (5…”
    Get full text
    Journal Article
  11. 11

    Full restoration of Brucella-infected dendritic cell functionality through Vγ9Vδ2 T helper type 1 crosstalk by Ni, Ming, Martire, Delphine, Scotet, Emmanuel, Bonneville, Marc, Sanchez, Francoise, Lafont, Virginie

    Published in PloS one (22-08-2012)
    “…Vγ9Vδ2 T cells play an important role in the immune response to infectious agents but the mechanisms contributing to this immune process remain to be better…”
    Get full text
    Journal Article
  12. 12
  13. 13
  14. 14

    Development of Predictive Value of Urinary Cytokine Profile Induced During Intravesical Bacillus Calmette-Guérin Instillations for Bladder Cancer by Rigaud, Jérôme, Leger, Alexandra, Devilder, Marie-Claire, Bouchot, Olivier, Bonneville, Marc, Scotet, Emmanuel

    Published in Clinical genitourinary cancer (01-08-2015)
    “…Micro-Abstract We describe a local reaction to intravesical bacillus Calmette-Guérin (BCG) instillations for the treatment of bladder cancer, with different…”
    Get full text
    Journal Article
  15. 15

    CD4 engagement by CD1d potentiates activation of CD4+ invariant NKT cells by Thedrez, Aurelie, de Lalla, Claudia, Allain, Sophie, Zaccagnino, Luca, Sidobre, Stephane, Garavaglia, Claudio, Borsellino, Giovanna, Dellabona, Paolo, Bonneville, Marc, Scotet, Emmanuel, Casorati, Giulia

    Published in Blood (01-07-2007)
    “…The CD4 coreceptor is crucial in the activation of major histocompatibility complex (MHC) class II restricted CD4 + T lymphocytes by binding the same MHC class…”
    Get full text
    Journal Article
  16. 16
  17. 17

    Human V gamma 9V delta 2 T cells: promising new leads for immunotherapy of infections and tumors by Bonneville, Marc, Scotet, Emmanuel

    Published in Current Opinion in Immunology (01-10-2006)
    “…V gamma 9V delta 2 T cells, a major human peripheral gamma delta T-cell subset, react in vitro against a wide array of microbial agents and tumor cells. This…”
    Get full text
    Journal Article
  18. 18

    Human Vγ9Vδ2 T cells: promising new leads for immunotherapy of infections and tumors by Bonneville, Marc, Scotet, Emmanuel

    Published in Current opinion in immunology (01-10-2006)
    “…Vγ9Vδ2 T cells, a major human peripheral γδ T-cell subset, react in vitro against a wide array of microbial agents and tumor cells. This broad reactivity…”
    Get full text
    Journal Article
  19. 19

    Beyond CAR T cells: Engineered Vγ9Vδ2 T cells to fight solid tumors by Rafia, Chirine, Harly, Christelle, Scotet, Emmanuel

    Published in Immunological reviews (01-11-2020)
    “…Despite recent significant progress in cancer immunotherapies based on adoptive cell transfer(s)(ACT), the eradication of cancers still represents a major…”
    Get full text
    Journal Article
  20. 20

    The Intracellular B30.2 Domain of Butyrophilin 3A1 Binds Phosphoantigens to Mediate Activation of Human V gamma 9V delta 2 T Cells by Sandstrom, Andrew, Peigne, Cassie-Marie, Leger, Alexandra, Crooks, James E, Konczak, Fabienne, Gesnel, Marie-Claude, Breathnach, Richard, Bonneville, Marc, Scotet, Emmanuel, Adams, Erin J

    Published in Immunity (Cambridge, Mass.) (17-04-2014)
    “…In humans, V gamma 9V delta 2 T cells detect tumor cells and microbial infections, including , through recognition of small pyrophosphate containing organic…”
    Get full text
    Journal Article